Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Holoclar

Holoclar 79,000 - 316,000 cells/cm2 living tissue equivalent · Abschnitt 4.8 · PDF-Seite 6

HOS-215680 · Präparat HOS-155496

Tabulated list of adverse reactions Adverse reactions reported in patients implanted with Holoclar in clinical studies and post-marketing experience are provided in the table. The following categories are used to rank the adverse reactions by frequency of occurrence: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1 000 to <1/100), rare (≥1/10 000 to <1/1 000), very rare (<1/10 000) and not known (cannot be estimated from the available data). Within each frequency grouping the adverse reactions are presented in the order of decreasing seriousness.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.